Connect with us

Hi, what are you looking for?


Philippines hopeful of vaccine manufacturing investments by 2022

The Philippines is hoping to attract investments for domestic vaccine manufacturing. — PHILIPPINE STAR/ MICHAEL VARCAS

INVESTMENTS for domestic vaccine manufacturing could start coming into the Philippines by next year, Trade Secretary Ramon M. Lopez said on Thursday.

Several firms are in talks with technology providers to locally produce coronavirus disease 2019 (COVID-19) vaccines.

“Hopefully, within this year or next year ay meron nang mga actual investments that will come in, once ma-settle din ang kanilang mga concern at mga requirements,” Mr. Lopez said at a briefing on Thursday.

The Board of Investments (BoI) last month said that the private sector is studying potential vaccine technology providers, facility costs, and domestic market demand for vaccines.

Science and Technology Undersecretary Rowena Cristina L. Guevara said two of the six companies in “advanced talks” with the government for vaccine manufacturing are “aggressive” in their plans.

“Based on what they have told us, parang kakayanin nilang mag-produce ng vaccines by late 2022 (they will try to produce vaccines by late 2022),” Ms. Guevara told an online news briefing.

Ms. Guevara said the two companies, which are targeting to manufacture COVID-19 vaccines, are eyeing a fill-and-finish facility that can be finished in less than two years.

Fill-and-finish facilities, in which the active ingredients are imported for local packaging, could be up in two or three years, BoI Executive Director Ma. Corazon H. Dichosa said. Companies will still need to obtain licenses to manufacture.

Initial work on the manufacturing facilities could start by 2022 or 2023, she said.

Some firms may start working immediately on COVID-19 vaccines to address domestic demand while others may start with regular flu vaccines.

Ms. Guevara said some of the local companies are planning to start manufacturing vaccines that are already “well established” such as measles and rubella, before making COVID-19 vaccines when clinical trials are done.

While she declined to name the companies, Ms. Guevara said one is a distributor of a South Korean company and is currently in talks with two companies to form a venture that includes the National Development Co. (NDC).

Another company has extensive facilities in Asia with a foreign partner that is manufacturing vaccines, while a third company is eyeing a fill-and-finish facility.

The fourth company is already in talks with the BoI and NDC, and is connected with a vaccine developer in Germany, while a fifth firm is a partner of a Chinese vaccine producer. A sixth company is looking to team up with a US company, and has already submitted a pre-feasibility study for plans for a fill-and-finish facility and later on, COVID-19 vaccines.

Mr. Lopez said that the government will help facilitate these firms’ entry into Philippine manufacturing.

Tutulungan din natin sila sa mga requirement sa FDA (Food and Drug Authority),” he said.

The BoI has said that such local manufacturing could provide supplies for the latter stages of the population’s inoculation against COVID-19, or for potential additional jabs.

The Philippine Economic Zone Authority (PEZA) has also said that an Israeli-Filipino investment could produce local COVID-19 vaccine manufacturing, but the investment promotion agency has not yet shared details. — Jenina P. Ibañez and Vann Marlo M. Villegas

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!



Virgin Orbit’s next satellite launch will take place from the UK, following the success of the “Straight Up” mission, which lifted off from Mojave...


Post Office collection and cash delivery workers are to stage a one-day strike later this month in a dispute over pay. Members of the...


UK consumers cut back on credit card borrowing in May amid fears over rising interest rates and a slowing economy driven by a cost...


London City airport is seeking to overturn its Saturday flight ban and raise by 40% the limit on its passenger numbers. A local residents’...


The bank said that it was introducing a £1,200-a-year pay increase from August 1, which would start to show in next month’s pay packets....


Postmasters caught up in the Horizon IT scandal say that they are still being “left in the dark” about a compensation package after the...

You May Also Like


Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...


Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...


Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...


As a traditionally rigid insurance industry becomes bogged down by antiquated processes and operations, a handful of industry leaders are seeking to shake things...

Disclaimer:, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.